Get the Stockscreener App
2.75
3.38%
0.09
Neonc Technologies Holdings Inc stock is traded at $2.75, with a volume of 106.95K.
It is up +3.38% in the last 24 hours and down -16.92% over the past month.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
See More
Previous Close:
$2.66
Open:
$2.66
24h Volume:
106.95K
Relative Volume:
0.64
Market Cap:
$79.21M
Revenue:
$40,000
Net Income/Loss:
$-38.64M
P/E Ratio:
-1.4934
EPS:
-1.8414
Net Cash Flow:
$-22.21M
1W Performance:
+8.70%
1M Performance:
-16.92%
6M Performance:
-46.71%
1Y Performance:
-74.63%
1-Day Range:
$2.66
$2.80
1-Week Range:
$2.501
$2.8655
52-Week Range:
$2.501
$12.00
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
Name
Neonc Technologies Holdings Inc
Sector
Industry
Phone
310 663 7831
Address
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
2.75 | 79.21M | 40,000 | -38.64M | -22.21M | -1.8414 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Neonc Technologies Holdings Inc Stock (NTHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-26 | Initiated | Roth Capital | Buy |
| May-19-26 | Initiated | Alliance Global Partners | Buy |
| May-18-26 | Initiated | Maxim Group | Buy |
| Apr-24-26 | Initiated | BTIG Research | Buy |
Neonc Technologies Holdings Inc Stock (NTHI) Latest News
NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors - GlobeNewswire Inc.
NeOnc Technologies Announces FDA Meeting on November 17, 2026, for NEO212 Progress - Kalkine Media
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com Canada
Form 4 Neonc Technologies Holdings Inc For: 27 September - Investing.com India
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com Nigeria
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com Australia
Neonc Technologies CFO Garnett sells $16,809 stock - Investing.com
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com UK
Neonc Technologies CFO Garnett sells $16,809 stock By Investing.com - Investing.com UK
NeOnc’s Delivery may Finally Change the Equation for Brain Cancer’s Next Frontier - GlobeNewswire Inc.
[8-K] NEONC TECHNOLOGIES HOLDINGS, INC. Reports Material Event - Stock Titan
NeOnc Charting New Nasal Route to Treating Brain Cancer - GlobeNewswire Inc.
Neonc Technologies CFO sells $16,809 in company stock - Investing.com
NeOnc Technologies (NTHI) CFO sells shares under preset plan - Stock Titan
NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution - Yahoo Finance
A $6 million payment kept NeOnc from issuing new shares - Stock Titan
NeOnc leaders (NTHI) keep buying after positive Phase 2a data - Stock Titan
NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results - TradingView
Neonc technologies CEO Thomas Chen buys $39,999 in stock - Investing.com
Neonc technologies CEO Amir Heshmatpour acquires $174,795 in stock - Investing.com
NeOnc Technologies (NTHI) CEO is buying more of his own stock - Stock Titan
NeOnc Technologies (NTHI) CFO adds shares in open-market buy - Stock Titan
NeOnc (NTHI) CEO adds shares in IRA trades - Stock Titan
NeOnc Technologies (NTHI) insider may sell $18,900 in stock - Stock Titan
48.9% had no cancer progression at six months in NeOnc’s 24-person study - Stock Titan
Neonc Technologies CEO Amir Heshmatpour buys $135,619 in shares - Investing.com
NeOnc (NTHI) CEO now holds 3.13M shares after stock buy - Stock Titan
Neonc Technologies Holdings, Briacell Therapeutics and Oncolytics Biotech Have Report Clinical and Regulatory Developments Across Brain, Breast and Colorectal Cancer - marketscreener.com
NeOnc Technologies Announces $15 Million Registered Direct Offering - The Globe and Mail
NeOnc Technologies Announces $15 Million Registered Direct Offering - The Globe and Mail
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com Nigeria
NeOnc raises USD 15m to advance Phase II CNS cancer programs after NEO100 efficacy readout - AllSci
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com India
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com Canada
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com UK
NeOnc Technologies Launches $15 Million Registered Direct Offering at $4.20 With Warrants - TradingView
NeOnc Technologies Company Profile & Introduction - Moomoo
NeOnc Technologies Holdings Secures $15 Million Registered Direct Offering After Positive Phase 2a Data and Insider Buying - Quiver Quantitative
NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data - marketscreener.com
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors - Stocktwits
NeOnc Technologies prices $15M registered direct offering - investing.com
NeOnc Technologies prices $15M registered direct offering By Investing.com - Investing.com Canada
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 - GlobeNewswire
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors - Yahoo Finance
Cancer-drug developer NeOnc plans a stock sale of about $15 million - Stock Titan
In a brain-cancer trial, 48.9% had no worsening at six months. NeOnc also redeemed $6M in stock. - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
NeOnc' Phase 2 Data Could Put Cancer on the Ropes - globenewswire.com
Nearly half had no cancer progression at six months. NeOnc plans to meet U.S. drug regulators. - Stock Titan
NTHI Q2 2026 Earnings: Wider-than-Expected Loss of -$0.58 per ShareEarnings Momentum Score - vinanet.vn
Neonc Technologies Holdings Inc Stock (NTHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neonc Technologies Holdings Inc Stock (NTHI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| KEITHLY GARNETT | Officer |
Sep 15 '26 |
Proposed Sale |
3.78 |
5,000 |
18,900 |
0 |
| Heshmatpour Amir F | CEO, President |
Sep 14 '26 |
Buy |
3.96 |
15,000 |
59,400 |
3,148,000 |
| CHEN THOMAS C | CEO |
Sep 14 '26 |
Buy |
3.81 |
5,242 |
19,998 |
24,503 |
| GARNETT KEITHLY | CFO |
Sep 14 '26 |
Buy |
3.89 |
257 |
1,001 |
242,357 |
| CHEN THOMAS C | CEO |
Sep 11 '26 |
Buy |
3.60 |
5,556 |
20,002 |
19,261 |
| Heshmatpour Amir F | CEO, President |
Sep 11 '26 |
Buy |
3.67 |
37,000 |
135,620 |
3,133,000 |
| CHEN THOMAS C | CEO |
Aug 18 '26 |
Buy |
5.49 |
12,757 |
69,998 |
13,705 |
| Heshmatpour Amir F | CEO, President |
Aug 18 '26 |
Buy |
5.54 |
9,000 |
49,860 |
3,096,000 |
| CHEN THOMAS C | CEO |
Aug 17 '26 |
Buy |
4.04 |
2,472 |
9,998 |
583,531 |
| Heshmatpour Amir F | CEO, President |
Aug 17 '26 |
Buy |
4.37 |
3,000 |
13,120 |
3,087,000 |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):